Tax increase should have minimal impact on India's drug industry

03/3/2013 | Economic Times (India), The

Excise tax increases on drug imports to India should have little impact on the current robust growth of the Indian pharmaceutical industry, according to a report by global analytics company Crisil. The firm projects a domestic growth rate year-over-year increase of 16% to 17% through 2014, coupled with export increases of 17%, as India increasingly taps into generics and manufacturing opportunities for bulk drugs.

View Full Article in:

Economic Times (India), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA